novo nordisk semaglutide tablet Article » PBD Novo Nordisk's Ozempic Sister Drug

People who developed serious stomach problems after taking Ozempic or another GLP-1 drug have filed lawsuits

Gastrointestinal adverse events were more common with semaglutide 7.2 mg (70.8%) compared with semaglutide 2.4 mg (61.2%) and placebo (42.8%), whereas dysesthesia was more common in the semaglutide 7.2 mg group (22.9%) than in the semaglutide 2.4 mg group (6%) and the placebo group (0.5%), Wharton and colleagues found

When you lose weight, you do not lose only fat

Levy said no single treatment works for everyone

Balanced Hormones Excess fat affects your hormone levels, so managing your weight can help you restore balance to your body

The Relevance of Glutathione Reductase Inhibition by Fluoxetine to Human Health and Disease: Insights Derived from a Combined Kinetic and Docking Study